Main > A1. CORP. INDEX. R-Rm > RedHill Biopharma Ltd./P C2

---

RedHill Biopharma Ltd./P C2's subsections
2010. 05.06. Scolr Pharma
2010. 08.30. IntelGenx
2012. 04.18. Onco.>Nausea &
2013. 01.07. Patent
2013. 12.31. Private Placement
2014. 01.14. Private Placement
2017. 04.13. Migraine
2019. 11.04. Gastro.>H. Pyl>USA>OK
2020. 02.25. Gastro.>Constipation>
2020. 03.09. Gastro.>H. Pyl>USA>Lau
2020. 04.06. IT COVID-19 Opaganib
2020. 04.17. IL COVID-19 Opaganib
2020. 04.27. IL COVID-19 Opaganib
2020. 05.08. IL COVID-19 Opaganib
2020. 11.04. U.S. Patent Allowance
2021. 02.23. USA COVID-19 Opaganib
2021. 08.23. 2 USA Patents
2021. 10.12. USA Patent
2023. 09.18. FDA sNDA Approval
2023. 11.27. FDA Grant of 5-Year>
2024. 01.25. USA Patent
2024. 03.11. USA Patent
2024. 05.06. CN Patent
2024. 09.30. USA Patent
Web-Site

RedHill Biopharma Ltd./P C2's products
This section has no products